Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries

Wiwan Worakunphanich, Sitaporn Youngkong, Wimon Suwankesawong, Claire Anderson and Montarat Thavorncharoensap
Additional contact information
Wiwan Worakunphanich: Doctor of Philosophy Program in Social, Economic, and Administrative Pharmacy, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand
Sitaporn Youngkong: Health Technology Assessment Graduate Program, Mahidol University, Bangkok 10400, Thailand
Wimon Suwankesawong: The College of Pharmaceutical and Health Consumer Protection of Thailand, Bangkok 10330, Thailand
Claire Anderson: School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK
Montarat Thavorncharoensap: Health Technology Assessment Graduate Program, Mahidol University, Bangkok 10400, Thailand

IJERPH, 2022, vol. 19, issue 8, 1-12

Abstract: Patients are recognized as important players in the pharmacovigilance system. This study aims to describe and compare the characteristics of patient reporting systems, reporting forms, awareness raising-activities, and the statistics related to patient reporting in the selected countries. Fifteen countries (eight Western countries and seven Asian countries) were purposively selected. A questionnaire survey was distributed to national pharmacovigilance authorities in those countries. Nine countries (five Western countries and four Asian countries) returned the questionnaire. A review of the websites of national pharmacovigilance centres was conducted. The proportion of patient reports in the selected Western countries ranged from 57.83% to 14.37%, while it was accounted for less than 1% in the selected Asian countries. Currently, patients in all nine countries can report adverse drug reactions online via a website. The number of clicks from the national pharmacovigilance website to reach the online reporting form range from one to five clicks. Countries with higher patient reporting rates seemed to share the following characteristics; provision of feedback, engagement with patient organizations, and implementation of several activities to raise the awareness of the general public on the importance of pharmacovigilance. To increase the number of patient reports, the strengths of each country’s system should be adopted.

Keywords: patient adverse drug reaction reporting; patient reporting system; ADR reporting; pharmacovigilance (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/8/4447/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/8/4447/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:8:p:4447-:d:788891

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().